Word

GC MOGAM

Status

Dead

Status Code

606

Status Date

Monday, October 12, 2020

Serial Number

87119997

Mark Type

4000

Filing Date

Thursday, July 28, 2016

Published for Opposition

Tuesday, July 11, 2017

Abandoned Date

Monday, October 12, 2020

Trademark Owner History

Green Cross Holdings Corporation - Owner At Publication

Classifications

5 Pharmaceuticals for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombophlebitis, Japanese Encephalitis, hepatitis, HIV, Hunter syndrome, hemophilia, arthritis, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, clostridium tetani, influenza, chronic pain and kidney diseases; pharmaceutical preparations for use in ocular or intraocular surgery, chemotherapy, dermatology and urology; blood plasma derivatives for medical purposes; vaccines; enzyme preparations for medical purposes; protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing and treatment of hepatitis B and influenza

35 Wholesale distributorships and retail stores featuring pharmaceutical products; Export and import agencies in the field of pharmaceutical products; Financial intermediary services, namely, facilitating the channeling of funds between lenders and borrowers by connecting those with a financial surplus with those having a financial deficit in the field of pharmaceutical products and medical equipment; Operation of a business for others, namely, wholesale distributorships and retail stores featuring pharmaceutical products; Procurement, namely, purchasing pharmaceutical products for other businesses

42 Research and development, laboratory and scientific research in the field of pharmaceuticals, vaccines, blood plasma preparations, recombinant proteins and antibodies

GREEN CROSS MOGAM

Trademark Events

Oct 13, 2020

Abandonment Notice E-Mailed - No Use Statement Filed

Oct 12, 2020

Abandonment - No Use Statement Filed

Mar 12, 2020

Notice Of Approval Of Extension Request E-Mailed

Mar 11, 2020

Extension 5 Granted

Mar 3, 2020

Extension 5 Filed

Mar 11, 2020

Case Assigned To Intent To Use Paralegal

Mar 3, 2020

Teas Extension Received

Aug 14, 2019

Notice Of Approval Of Extension Request E-Mailed

Aug 12, 2019

Extension 4 Granted

Aug 12, 2019

Extension 4 Filed

Aug 12, 2019

Teas Extension Received

Feb 14, 2019

Notice Of Approval Of Extension Request E-Mailed

Feb 12, 2019

Extension 3 Granted

Feb 12, 2019

Extension 3 Filed

Feb 12, 2019

Teas Extension Received

Sep 6, 2018

Notice Of Approval Of Extension Request E-Mailed

Sep 4, 2018

Extension 2 Granted

Sep 4, 2018

Extension 2 Filed

Sep 4, 2018

Teas Extension Received

Feb 1, 2018

Notice Of Approval Of Extension Request E-Mailed

Jan 30, 2018

Extension 1 Granted

Jan 30, 2018

Extension 1 Filed

Jan 30, 2018

Teas Extension Received

Sep 5, 2017

Noa E-Mailed - Sou Required From Applicant

Jul 11, 2017

Official Gazette Publication Confirmation E-Mailed

Jul 11, 2017

Published For Opposition

Jun 21, 2017

Notification Of Notice Of Publication E-Mailed

Jun 6, 2017

Law Office Publication Review Completed

Jun 2, 2017

Approved For Pub - Principal Register

Jun 2, 2017

Teas/Email Correspondence Entered

Jun 2, 2017

Correspondence Received In Law Office

May 26, 2017

Teas Request For Reconsideration Received

Apr 29, 2017

Notification Of Final Refusal Emailed

Apr 29, 2017

Final Refusal E-Mailed

Apr 29, 2017

Final Refusal Written

Apr 28, 2017

Teas/Email Correspondence Entered

Apr 28, 2017

Correspondence Received In Law Office

Apr 16, 2017

Assigned To Lie

Apr 4, 2017

Teas Response To Office Action Received

Nov 8, 2016

Notification Of Priority Action E-Mailed

Nov 8, 2016

Priority Action E-Mailed

Nov 8, 2016

Priority Action Written

Nov 8, 2016

Assigned To Examiner

Aug 3, 2016

Notice Of Pseudo Mark E-Mailed

Aug 2, 2016

New Application Office Supplied Data Entered In Tram

Aug 1, 2016

New Application Entered In Tram